XML 96 R83.htm IDEA: XBRL DOCUMENT v3.24.3
Reportable Segment Information - Segment Revenue, Operating (Loss) Income and Depreciation and Amortization (Detail) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]      
Revenue $ 126,078 $ 132,584 $ 99,951
Operating (loss) income (5,645) 5,150 (22,097)
Depreciation and amortization 8,694 8,522 9,142
Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenue 126,078 132,584 99,951
Operating (loss) income 10,862 17,721 (9,850)
Operating Segments [Member] | Medical Device [Member]      
Segment Reporting Information [Line Items]      
Revenue 97,508 105,783 72,389
Operating (loss) income (2,239) 5,084 (22,923)
Depreciation and amortization 7,901 7,874 8,368
Operating Segments [Member] | In Vitro Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Revenue 28,570 26,801 27,562
Operating (loss) income 13,101 12,637 13,073
Depreciation and amortization 377 321 355
Corporate [Member]      
Segment Reporting Information [Line Items]      
Operating (loss) income (16,507) (12,571) (12,247)
Depreciation and amortization $ 416 $ 327 $ 419